Henry Schein, Inc. (NASDAQ:HSIC) Sees Large Decrease in Short Interest

Henry Schein, Inc. (NASDAQ:HSIC) was the target of a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 4,168,764 shares, a drop of 12.8% from the February 12th total of 4,779,133 shares. Currently, 3.7% of the company’s stock are sold short. Based on an average daily trading volume, of 1,715,124 shares, the days-to-cover ratio is currently 2.4 days. Based on an average daily trading volume, of 1,715,124 shares, the days-to-cover ratio is currently 2.4 days. Currently, 3.7% of the company’s stock are sold short.

Analysts Set New Price Targets

HSIC has been the subject of several recent analyst reports. JPMorgan Chase & Co. raised their target price on Henry Schein from $78.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, February 25th. Morgan Stanley increased their price target on Henry Schein from $58.00 to $61.00 and gave the company an “underweight” rating in a report on Wednesday, February 25th. UBS Group raised their price objective on Henry Schein from $79.00 to $87.00 and gave the company a “neutral” rating in a research note on Wednesday, February 25th. Mizuho lifted their price objective on Henry Schein from $81.00 to $88.00 and gave the stock a “neutral” rating in a report on Wednesday, February 25th. Finally, Wall Street Zen lowered Henry Schein from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 14th. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Henry Schein has a consensus rating of “Hold” and an average price target of $85.58.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $73.12 on Thursday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.76 and a current ratio of 1.38. Henry Schein has a 1 year low of $60.56 and a 1 year high of $89.29. The firm’s 50-day simple moving average is $77.96 and its 200-day simple moving average is $72.97. The firm has a market cap of $8.39 billion, a PE ratio of 22.36, a price-to-earnings-growth ratio of 2.22 and a beta of 0.88.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.30 by $0.04. The business had revenue of $3.44 billion during the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a return on equity of 15.16% and a net margin of 3.02%.The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the firm earned $1.19 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities analysts forecast that Henry Schein will post 4.74 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Philip A. Laskawy sold 2,844 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $80.36, for a total value of $228,543.84. Following the completion of the transaction, the director directly owned 21,961 shares in the company, valued at approximately $1,764,785.96. This represents a 11.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kurt P. Kuehn sold 2,844 shares of the firm’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $78.96, for a total transaction of $224,562.24. Following the sale, the director directly owned 15,420 shares of the company’s stock, valued at approximately $1,217,563.20. The trade was a 15.57% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 104,556 shares of company stock valued at $8,476,351. Insiders own 1.08% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

A number of institutional investors have recently made changes to their positions in HSIC. CYBER HORNET ETFs LLC bought a new position in Henry Schein during the second quarter worth $25,000. MUFG Securities EMEA plc bought a new stake in Henry Schein during the second quarter valued at $27,000. Flagship Harbor Advisors LLC acquired a new stake in shares of Henry Schein during the fourth quarter worth $30,000. Federated Hermes Inc. bought a new position in shares of Henry Schein in the 4th quarter worth about $32,000. Finally, Los Angeles Capital Management LLC bought a new position in shares of Henry Schein in the 4th quarter worth about $37,000. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.